Compound information
- Natural Products
- ZC1027053
- Molecular Formula
- C17H26N2O5S
- Molecular Weight
- 370.156242932 g/mol
- Structure
-
- IUPAC Name
- ethyl 4-[3-(isopropoxymethyl)phenyl]sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C17H26N2O5S/c1-4-23-17(20)18-8-10-19(11-9-18)25(21,22)16-7-5-6-15(12-16)13-24-14(2)3/h5-7,12,14H,4,8-11,13H2,1-3H3
- InChI Key
- MCVFBYOVOWMTER-UHFFFAOYSA-N
- SMILES
- CCOC(=O)N1CCN(S(=O)(=O)c2cccc(COC(C)C)c2)CC1
- Source
- ZINC000096182594
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 25 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 76.15 Å2 | LogP | 2.227 |
LogS | -3.371 | LogD | 2.983 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.106 | Pgp substrate | 0.006 |
HIA | 0.977 | F20 % | 0.987 |
F30 % | 0.885 | Caco-2 | -4.36 |
MDCK | -4.781 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.138 | PPB | 49.011 |
VD | 1.281 | Fu | 0.719 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.017 | CYP1A2 substrate | 0.594 |
CYP2A6 substrate | 0.537 | CYP2B6 substrate | 0.693 |
CYP2C19 inhibitor | 0.989 | CYP2C19 substrate | 0.842 |
CYP2C8 substrate | 0.696 | CYP2C9 inhibitor | 0.908 |
CYP2C9 substrate | 0.829 | CYP2D6 inhibitor | 0.011 |
CYP2D6 substrate | 0.75 | CYP2E1 substrate | 0.498 |
CYP3A4 inhibitor | 0.113 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.421 | CL | 4.446 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.899 | Hepatotoxicity | 0.921 |
Mutagenicity | 0.257 | Rat Oral Acute Toxicity | 0.055 |
FDAMDD | 0.032 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.927 | Eye Corrosion | 0.002 |
Eye Irritation | 0.006 | Respiratory Toxicity | 0.097 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.662 | IGC50 | 2.228 |
LC50FM | 2.871 | LC50DM | 0.086 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.273 | NR-AR-LBD | 0.288 |
NR-AhR | 0.08 | NR-Aromatase | 0.422 |
NR-ER | 0.286 | NR-ER-LBD | 0.39 |
NR-PPAR-gamma | 0.125 | SR-ARE | 0.652 |
SR-ATAD5 | 0.319 | SR-HSE | 0.083 |
SR-MMP | 0.017 | SR-p53 | 0.026 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.